BIM 23A760
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BIM 23A760, covering 2015-09-07 to 2016-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly [Phase 2]